Close Menu


NanoString Technologies this week took another step toward commercializing its Breast Cancer Intrinsic Subtyping Assay for clinical use by establishing a new diagnostics business unit to focus on selling the test, while moving sales of its research products to its newly named lif

NanoString Launches Second Validation Study for PAM50
[This article has been updated from a previous version to correct details about NanoString's PAM50 test.]

NanoString Technologies has appointed Joseph Beechem as senior vice president of research and development.

DiaGenic said this week that CEO Erik Christensen has resigned.
Christensen will "continue to provide consultative support to the company on partner interactions, licensing and other business activities," DiaGenic said in a statement.

Joseph Beechem has left his position as head of advanced sequencing and global sequencing chemistry, biochemistry, and biophysics at Life Technologies to join NanoString as senior vice president of research and development.

NanoString Technologies has introduced a new version of its nCounter human miRNA expression assay kit, which includes content from miRBase 18.

NEW YORK (GenomeWeb News) – NanoString Technologies has received $15 million in debt financing from Oxford Finance and Silicon Valley Bank.

NEW YORK (GenomeWeb News) – NanoString Technologies today said that it has raised $20 million in a Series D round of financing.


A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.